Improvement of absorbability, osteoconductivity, and strength of a β-tricalcium phosphate spacer for opening wedge high tibial osteotomy: clinical evaluations with 106 patients.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
05 Jun 2024
Historique:
received: 08 06 2023
accepted: 22 05 2024
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 5 6 2024
Statut: epublish

Résumé

An ideal synthetic spacer for medial opening wedge high tibial osteotomy (MOWHTO) has not yet been developed. The authors have developed a new β-tricalcium phosphate (β-TCP) spacer with 60% porosity (N-CP60) by modifying the micro- and macro-pore structures of a conventional β-TCP spacer (CP60) that is widely used in clinical practice. The purpose of this study was to compare the absorbability, osteoconductivity, and in vivo strength of the N-CP60 spacer with those of the CP60 spacer, when used in MOWHTO. First, the porosity, diameter distribution of macro- and micropores, and compressive strength of each β-TCP block were examined using methodology of biomaterial science. Secondly, a clinical study was performed using a total of 106 patients (106 knees) with MOWHTO, who were followed up for 18 months after surgery. In these knees, the N-CP60 and CP-60 spacers were implanted into 49 tibias and 57 tibias, respectively. The absorbability and osteoconductivity were radiologically evaluated by measuring the area of the implanted spacer remaining unabsorbed and assessing with the Hemert's score, respectively. The incidence of cracking in the implanted spacers was determined using computed radiography. Statistical comparisons were made with non-parametric tests. The significance level was set at p = 0.05. The N-CP60 and CP60 blocks had almost the same porosity (mean, 61.0% and 58.7%, respectively). The diameter of macropores was significantly larger (p < 0.0001) in the N-CP60 block than in the CP60 block, while the diameter of micropores was significantly smaller (p = 0.019) in the N-CP60 block. The ultimate strength of the N-CP60 block (median, 36.8 MPa) was significantly greater (p < 0.01) than that of the CP60 block (31.6 MPa). As for the clinical evaluations, the absorption rate of the N-CP60 spacer at 18 months after implantation (mean, 48.0%) was significantly greater (p < 0.001) than that of the CP60 spacer (29.0%). The osteoconductivity of the N-CP60 spacer was slightly but significantly higher (p = 0.0408) than that of the CP60 spacer only in zone 1. The incidence of in vivo cracking of the posteriorly located N-CP60 spacer at one month (mean, 75.5%) was significantly lower (p = 0.0035) than that of the CP60 spacer (91.2%). The absorbability, osteoconductivity, and compressive strength of the new N-CP60 spacer were significantly improved by modifying the macro- and micro-pore structures, compared with the conventional CP60 spacer. The N-CP60 spacer is more clinically useful than the CP60 spacer. H29-0002.

Sections du résumé

BACKGROUND BACKGROUND
An ideal synthetic spacer for medial opening wedge high tibial osteotomy (MOWHTO) has not yet been developed. The authors have developed a new β-tricalcium phosphate (β-TCP) spacer with 60% porosity (N-CP60) by modifying the micro- and macro-pore structures of a conventional β-TCP spacer (CP60) that is widely used in clinical practice. The purpose of this study was to compare the absorbability, osteoconductivity, and in vivo strength of the N-CP60 spacer with those of the CP60 spacer, when used in MOWHTO.
METHODS METHODS
First, the porosity, diameter distribution of macro- and micropores, and compressive strength of each β-TCP block were examined using methodology of biomaterial science. Secondly, a clinical study was performed using a total of 106 patients (106 knees) with MOWHTO, who were followed up for 18 months after surgery. In these knees, the N-CP60 and CP-60 spacers were implanted into 49 tibias and 57 tibias, respectively. The absorbability and osteoconductivity were radiologically evaluated by measuring the area of the implanted spacer remaining unabsorbed and assessing with the Hemert's score, respectively. The incidence of cracking in the implanted spacers was determined using computed radiography. Statistical comparisons were made with non-parametric tests. The significance level was set at p = 0.05.
RESULTS RESULTS
The N-CP60 and CP60 blocks had almost the same porosity (mean, 61.0% and 58.7%, respectively). The diameter of macropores was significantly larger (p < 0.0001) in the N-CP60 block than in the CP60 block, while the diameter of micropores was significantly smaller (p = 0.019) in the N-CP60 block. The ultimate strength of the N-CP60 block (median, 36.8 MPa) was significantly greater (p < 0.01) than that of the CP60 block (31.6 MPa). As for the clinical evaluations, the absorption rate of the N-CP60 spacer at 18 months after implantation (mean, 48.0%) was significantly greater (p < 0.001) than that of the CP60 spacer (29.0%). The osteoconductivity of the N-CP60 spacer was slightly but significantly higher (p = 0.0408) than that of the CP60 spacer only in zone 1. The incidence of in vivo cracking of the posteriorly located N-CP60 spacer at one month (mean, 75.5%) was significantly lower (p = 0.0035) than that of the CP60 spacer (91.2%).
CONCLUSIONS CONCLUSIONS
The absorbability, osteoconductivity, and compressive strength of the new N-CP60 spacer were significantly improved by modifying the macro- and micro-pore structures, compared with the conventional CP60 spacer. The N-CP60 spacer is more clinically useful than the CP60 spacer.
TRIAL REGISTRATION NUMBER BACKGROUND
H29-0002.

Identifiants

pubmed: 38840163
doi: 10.1186/s12891-024-07533-8
pii: 10.1186/s12891-024-07533-8
doi:

Substances chimiques

Calcium Phosphates 0
beta-tricalcium phosphate 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

441

Informations de copyright

© 2024. The Author(s).

Références

Staubli AE, De Simoni C, Babst R, et al. TomoFix: a new LCP-concept for open wedge osteotomy of the medial proximal tibia–early results in 92 cases. Injury. 2003;34:55–62.
doi: 10.1016/j.injury.2003.09.025
Lobenhoffer P, Agneskirchner JD. Improvements in surgical technique of valgus high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc. 2003;11(3):132–8.
pubmed: 12774149 doi: 10.1007/s00167-002-0334-7
Amendola A, Panarella L. High tibial osteotomy for the treatment of unicompartmental arthritis of the knee. Orthop Clin North Am. 2005;36(4):497–504.
pubmed: 16164954 doi: 10.1016/j.ocl.2005.05.009
Koshino T, Murase T, Saito T. Medial opening-wedge high tibial osteotomy with use of porous hydroxyapatite to treat medial compartment osteoarthritis of the knee. J Bone Joint Surg Am. 2003;85(1):78–85.
pubmed: 12533576 doi: 10.2106/00004623-200301000-00013
Pape D, Kohn D, Van Giffen N, et al. Differences in fixation stability between spacer plate and plate fixator following high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc. 2013;21(1):82–9.
pubmed: 21983702 doi: 10.1007/s00167-011-1693-8
Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002;84:454–64.
pubmed: 11886919 doi: 10.2106/00004623-200203000-00020
Spahn G, Wittig R. Primary stability of various implants in tibial opening wedge osteotomy: a biomechanical study. J Orthop Sci. 2002;7(6):683–7.
pubmed: 12486473 doi: 10.1007/s007760200121
Amendola A, Fowler PJ, Litchfield R, et al. Opening wedge high tibial osteotomy using a novel technique: early results and complications. J Knee Surg. 2004;17(3):164–9.
pubmed: 15366272 doi: 10.1055/s-0030-1248216
Chazono M, Tanaka T, Komaki H, et al. Bone formation and bioresorption after implantation of injectable beta-tricalcium phosphate granules–hyaluronate complex in rabbit bone defects. J Biomed Mater Res A. 2004;70:542–9.
pubmed: 15307158 doi: 10.1002/jbm.a.30094
Yacobucci GN, Cocking MR. Union of medial opening-wedge high tibial osteotomy using a corticocancellous proximal tibial wedge allograft. Am J Sports Med. 2008;36(4):713–9.
pubmed: 18227231 doi: 10.1177/0363546507312646
Gouin F, Yaouanc F, Waast D, et al. Open wedge high tibial osteotomies: calcium-phosphate ceramic spacer versus autologous bonegraft. Orthop Traumatol Surg Res. 2010;96:637–45.
pubmed: 20832381 doi: 10.1016/j.otsr.2010.03.022
Lee SC, Jung KA, Nam CH, et al. The short-term follow-up results of open wedge high tibial osteotomy with using an Aescula open wedge plate and an allogenic bone graft: the minimum 1-year follow-up results. Clin Orthop Surg. 2010;2(1):47–54.
pubmed: 20191001 pmcid: 2824095 doi: 10.4055/cios.2010.2.1.47
Lash NJ, Feller JA, Batty LM, et al. Bone grafts and bone substitutes for opening-wedge osteotomies of the knee: a systematic review. Arthroscopy. 2015;31(4):720–30.
pubmed: 25595695 doi: 10.1016/j.arthro.2014.09.011
Haghpanah B, Kaseb MH, Espandar R, et al. No difference in union and recurrence rate between iliac crest autograft versus allograft following medial opening wedge high tibial osteotomy: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2021;29(10):3375–81.
pubmed: 32839849 doi: 10.1007/s00167-020-06240-w
Zaffagnini S, Dal Fabbro G, Lucidi GA, et al. Personalised opening wedge high tibial osteotomy with patient-specific plates and instrumentation accurately controls coronal correction and posterior slope: results from a prospective first case series. Knee. 2023;44:89–99.
pubmed: 37562120 doi: 10.1016/j.knee.2023.07.011
Grottoli CF, Cingolani A, Zambon F, et al. Simulated performance of a xenohybrid bone graft (SmartBone®) in the treatment of acetabular prosthetic peconstruction. J Funct Biomater. 2019;10(4):53.
pubmed: 31766685 pmcid: 6963854 doi: 10.3390/jfb10040053
Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res. 2000;371:10–27.
doi: 10.1097/00003086-200002000-00003
Onodera J, Kondo E, Omizu N, et al. Beta-tricalcium phosphate shows superior absorption rate and osteoconductivity compared to hydroxyapatite in open-wedge high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc. 2014;22(11):2763–70.
pubmed: 24045917 doi: 10.1007/s00167-013-2681-y
Smith J, Wilson A, Thomas N. Osteotomy around the knee: evolution, principles and results. Knee Surg Sports Traumatol Arthrosc. 2013;21(1):3–22.
pubmed: 23052110 doi: 10.1007/s00167-012-2206-0
Takeuchi R, Ishikawa H, Aratake M, et al. Medial opening wedge high tibial osteotomy with early full weight bearing. Arthroscopy. 2009;25(1):46–53.
pubmed: 19111218 doi: 10.1016/j.arthro.2008.08.015
Altermatt S, Schwöbel M, Pochon J. Operative treatment of solitary bone cysts with tricalcium phosphate ceramic. A 1 to 7 year follow-up. Eur J Pediatr Surg. 1992;2(03):180–2.
pubmed: 1498113 doi: 10.1055/s-2008-1063435
.Chatterjea A, Van Der Stok J, Danoux CB, et al. Inflammatory response and bone healing capacity of two porous calcium phosphate ceramics in critical size cortical bone defects. J Biomed Mater Res A. 2014;102(5):1399–407.
pubmed: 23733500 doi: 10.1002/jbm.a.34815
Dorozhkin SV. Bioceramics of calcium orthophosphates. Biomaterials. 2010;31(7):1465–85.
pubmed: 19969343 doi: 10.1016/j.biomaterials.2009.11.050
Yuan H, Fernandes H, Habibovic P, et al. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci USA. 2010;107(31):13614–9.
pubmed: 20643969 pmcid: 2922269 doi: 10.1073/pnas.1003600107
Hwang JW, Park JS, Lee JS, et al. Comparative evaluation of three calcium phosphate synthetic block bone graft materials for bone regeneration in rabbit calvaria. J Biomed Mater Res B Appl Biomater. 2012;100(8):2044–52.
pubmed: 22865716 doi: 10.1002/jbm.b.32768
Tanaka T, Komaki H, Chazono M, et al. Basic research and clinical application of beta-tricalcium phosphate (β-TCP). Morphologie. 2017;101(334):164–72.
pubmed: 28462796 doi: 10.1016/j.morpho.2017.03.002
Ozalay M, Sahin O, Akpinar S, et al. Remodeling potentials of biphasic calcium phosphate granules in open wedge high tibial osteotomy. Arch Orthop Trauma Surg. 2009;129(6):747–52.
pubmed: 19015864 doi: 10.1007/s00402-008-0781-9
Ribeiro GBM, Trommer RM, dos Santos LA, et al. Novel method to produce β-TCP scaffolds. Mater lett. 2011;65(2):275–7.
doi: 10.1016/j.matlet.2010.09.066
Tricoteaux A, Rguiti E, Chicot D, et al. Influence of porosity on the mechanical properties of microporous β-TCP bioceramics by usual and instrumented Vickers microindentation. J Eur Ceram Soc. 2011;31(8):1361–9.
doi: 10.1016/j.jeurceramsoc.2011.02.005
Putri TS, Hayashi K, Ishikawa K. Bone regeneration using β-tricalcium phosphate (β-TCP) block with interconnected pores made by setting reaction of β-TCP granules. J Biomed Mater Res A. 2020;108(3):625–32.
pubmed: 31742920 doi: 10.1002/jbm.a.36842
Yamadi S, Kobayashi S. Effects of strain rate on the mechanical properties of tricalcium phosphate/poly(L: -lactide) composites. J Mater Sci Mater Med. 2009;1:67–74.
doi: 10.1007/s10856-008-3553-8
Yabuuchi K, Kondo E, Onodera J, et al. Clinical outcomes and complications during and after medial open-wedge high tibial osteotomy using a locking plate: a 3- to 7-year follow-up study. Orthop J Sports Med. 2020;8(6):2325967120922535.
pubmed: 32551326 pmcid: 7281888 doi: 10.1177/2325967120922535
Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502.
pubmed: 13498604 pmcid: 1006995 doi: 10.1136/ard.16.4.494
Brosset T, Pasquier G, Migaud H, et al. Opening wedge high tibial osteotomy performed without filling the defect but with locking plate fixation (TomoFix™) and early weight-bearing: prospective evaluation of bone union, precision and maintenance of correction in 51 cases. Orthop Traumatol Surg Res. 2011;97(7):705–11.
pubmed: 22001198 doi: 10.1016/j.otsr.2011.06.011
van Hemert WL, Willems K, Anderson PG, et al. Tricalcium phosphate granules or rigid wedge preforms in open wedge high tibial osteotomy: a radiological study with a new evaluation system. Knee. 2004;11(6):451–6.
pubmed: 15581763 doi: 10.1016/j.knee.2004.08.004
Lysholm J, Gillquist J. Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med. 1982;10(3):150–4.
pubmed: 6896798 doi: 10.1177/036354658201000306
Aoki Y, Yasuda K, Mikami S, et al. Inverted V-shaped high tibial osteotomy compared with closing-wedge high tibial osteotomy for osteoarthritis of the knee: ten-year follow-up result. J Bone Joint Surg Br. 2006;88(10):1336–40.
pubmed: 17012424 doi: 10.1302/0301-620X.88B10.17532
Yasuda K, Majima T, Tsuchida T, et al. A ten-to 15-year follow-up observation of high tibial osteotomy in medial compartment osteoarthrosis. Clin Orthop Relat Res. 1992;282:186–95.
doi: 10.1097/00003086-199209000-00024
Tanaka T, Kumagae Y, Chazono M, et al. A novel evaluation system to monitor bone formation and β-tricalcium phosphate resorption in opening wedge high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc. 2015;23(7):2007–11.
pubmed: 24497055 doi: 10.1007/s00167-014-2870-3
Fujita R, Yokoyama A, Kawasaki T, et al. Bone augmentation osteogenesis using hydroxyapatite and beta-tricalcium phosphate blocks. J Oral Maxillofac Surg. 2003;61:1045–53.
pubmed: 12966480 doi: 10.1016/S0278-2391(03)00317-3
Chazono M, Tanaka T, Kitasato S, et al. Electron microscopic study on bone formation and bioresorption after implantation of beta-tricalcium phosphate in rabbit models. J Orthop Sci. 2008;13:550–5.
pubmed: 19089543 doi: 10.1007/s00776-008-1271-1
Juhasz JA, Best SM, Auffret AD, et al. Biological control of apatite growth in simulated body fluid and human blood serum. J Mater Sci Mater Med. 2008;19:1823–9.
pubmed: 18157508 doi: 10.1007/s10856-007-3344-7
Kuroda K, Okido M. Hydroxyapatite coating of titanium implants using hydroprocessing and evaluation of their osteoconductivity. Bioinorg Chem Appl. 2012;2012:730693.
pubmed: 22400015 pmcid: 3287042 doi: 10.1155/2012/730693
Wenisch S, Stahl JP, Horas U, et al. In vivo mechanisms of hydroxyapatite ceramic degradation by osteoclasts: fine structural microscopy. J Biomed Mater Res A. 2003;67(3):713–8.
pubmed: 14613217 doi: 10.1002/jbm.a.10091
Yamasaki N, Hirao M, Nanno K, et al. A comparative assessment of synthetic ceramic bone substitutes with different composition and microstructure in rabbit femoral condyle model. J Biomed Mater Res B Appl Biomater. 2009;91(2):788–98.
pubmed: 19572298 doi: 10.1002/jbm.b.31457
Bohner M, Santoni BLG, Döbelin N. β-tricalcium phosphate for bone substitution: synthesis and properties. Acta Biomater. 2020;113:23–41.
pubmed: 32565369 doi: 10.1016/j.actbio.2020.06.022
Kakuta A, Tanaka T, Chazono M, et al. Effects of micro-porosity and local BMP-2 administration on bioresorption of β-TCP and new bone formation. Biomaterials Res. 2019;23(1):1–9.
doi: 10.1186/s40824-019-0161-2
Duan R, Barbieri D, De Groot F, et al. Modulating bone regeneration in rabbit condyle defects with three surface-structured tricalcium phosphate ceramics. ACS Biomater Sci Eng. 2018;4(9):3347–55.
pubmed: 30221192 pmcid: 6134343 doi: 10.1021/acsbiomaterials.8b00630
Davison N, Luo X, Schoenmaker T, et al. Submicron-scale surface architecture of tricalcium phosphate directs osteogenesis in vitro and in vivo. Eur Cell Mater. 2014;27(2):281–97.
pubmed: 24733686 doi: 10.22203/eCM.v027a20
Feng B, Jinkang Z, Zhen W, et al. The effect of pore size on tissue ingrowth and neovascularization in porous bioceramics of controlled architecture in vivo. Biomed Mater. 2011;6(1):015007.
pubmed: 21206002 doi: 10.1088/1748-6041/6/1/015007
Akao M, Aoki H, Kato K, et al. Dense polycrystalline β-tricalcium phosphate for prosthetic applications. J Mater Sci. 1982;17:343–6.
doi: 10.1007/BF00591468

Auteurs

Jun Yamaguchi (J)

Knee Research Center, Yagi Orthopaedic Hospital, 1-35, Nishino-3-5, Nishi-ku, Sapporo, Hokkaido, 063-0033, Japan.

Eiji Kondo (E)

Centre for Sports Medicine, Hokkaido University Hospital, Kita-14, Nishi-5, Kita-ku, Sapporo, Hokkaido, 060-8648, Japan. eijik@med.hokudai.ac.jp.

Kazunori Yasuda (K)

Knee Research Center, Yagi Orthopaedic Hospital, 1-35, Nishino-3-5, Nishi-ku, Sapporo, Hokkaido, 063-0033, Japan.

Jun Onodera (J)

Knee Research Center, Yagi Orthopaedic Hospital, 1-35, Nishino-3-5, Nishi-ku, Sapporo, Hokkaido, 063-0033, Japan.

Koji Yabuuchi (K)

Knee Research Center, Yagi Orthopaedic Hospital, 1-35, Nishino-3-5, Nishi-ku, Sapporo, Hokkaido, 063-0033, Japan.

Takuma Kaibara (T)

Department of Orthopaedic Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita-15 Nishi-7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.

Kimiaki Takami (K)

Laboratory of Product Development, Olympus Termo Biomaterials Corporation, 1002-1, Shimonagakubo, Nagaizumi-cho, Shizuoka, 413-0934, Japan.

Norimasa Iwasaki (N)

Department of Orthopaedic Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Kita-15 Nishi-7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.

Tomonori Yagi (T)

Knee Research Center, Yagi Orthopaedic Hospital, 1-35, Nishino-3-5, Nishi-ku, Sapporo, Hokkaido, 063-0033, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH